News
Maria Pasqual was a flower farmer in Maili, loved by those who encountered her. The family who lives next door to her farm ...
DEAR MISS MANNERS: I am a gentleman who strives to live a mannerly life. In that regard, when riding public transportation, I ...
18hon MSN
There's a clear downside to the Norwegian policy that encourages allowing elderly people to live at home for as long as ...
12hon MSN
The suspect told the victim to “shut up,'' sparking a dispute in which she became "aggressive'' and he walloped her multiple ...
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...
FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.
The Food and Drug Administration (FDA) has approved Ekterly ® (sebetralstat) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.
While mom was alive, we thanked God for the time she spent with us. Her life was much more interesting and fascinating than I ...
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
Today's advice from Dear Abby. DEAR ABBY: I live five hours away from my hometown. My mom is 98 and in assisted living there.
After facing an unexpected regulatory delay last month, KalVista Pharmaceuticals has leapt into the commercial realm with the ...
Orsini, a leader in rare disease pharmacy solutions, has been chosen by KalVista Pharmaceuticals as a specialty pharmacy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results